AASLD practice guidelines: The past, the present, and the future

Hepatology

Volumn 63, Issue 1, 2016, Pages 31-34

  Merriman, Raphael B ^a   Tran, Tram T ^b  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC HEPATITIS B; CLINICAL PRACTICE; CONFLICT OF INTEREST; HEALTH CARE COST; HUMAN; LIVER DISEASE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; HEPATITIS B, CHRONIC;

ANTIVIRUS AGENT;

ANTIVIRAL AGENTS; HEPATITIS B, CHRONIC; HUMANS;

EID: 84951778778     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28345     Document Type: Article

References (6)

1. Graham R, Mancher M, Miller Wolman D, Greenfield S, Steinberg E, eds. Clinical Practice Guidelines We Can Trust. Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Washington, DC: National Academies Press; 2011.
2. Guyatt GH, Oxman AD, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al.; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-926.
3. Terrault NA, Bzowej NH, Chang K-M, Hwang JP, Jonas MM, Murad MH AASLD guidelines for treatment of chronic hepatitis B. Hepatology 2016;63:261-283.
4. Lok ASF, McMahon BJ, Brown RS, Jr., Wong JB, Ahmed AT, Farah W, et al. Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis. Hepatology 2016;63:284-306.
5. Jonas MM, Lok ASF, McMahon BJ, Brown RS, Jr., Wong JB, Ahmed AT, et al. Hepatology 2016;63:307-318.
6. Brown RS, Jr., McMahon BJ, Lok ASF, Wong JB, Ahmed AT, Mouchli MA, et al. Hepatology 2016;63:319-333.